Currently, there are 739.05M common shares owned by the public and among those 738.05M shares have been available to trade.
The company’s stock has a 5-day price change of 2.14% and 7.86% over the past three months. PPL shares are trading 11.55% year to date (YTD), with the 12-month market performance up to 36.03% higher. It has a 12-month low price of $26.79 and touched a high of $36.64 over the same period. PPL has an average intraday trading volume of 5.41 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 3.18%, 4.11%, and 10.66% respectively.
Institutional ownership of PPL Corp (NYSE: PPL) shares accounts for 79.04% of the company’s 739.05M shares outstanding.
It has a market capitalization of $26.76B and a beta (3y monthly) value of 0.69. The stock’s trailing 12-month PE ratio is 30.23, while the earnings-per-share (ttm) stands at $1.20. The company has a PEG of 4.07 and a Quick Ratio of 0.71 with the debt-to-equity ratio at 1.19. Price movements for the stock have been influenced by the stock’s volatility, which stands at 1.97% over the week and 2.60% over the month.
Analysts forecast that PPL Corp (PPL) will achieve an EPS of 0.54 for the current quarter, 0.39 for the next quarter and 1.96 for current fiscal year. The lowest estimate earnings-per-share for the quarter is 0.44 while analysts give the company a high EPS estimate of 0.44. Comparatively, EPS for the current quarter was 0.54 a year ago. Earnings per share for the fiscal year are expected to increase by 7.48%, and 7.66% over the next financial year. EPS should grow at an annualized rate of 7.43% over the next five years, compared to -12.75% over the past 5-year period.
Looking at the support for the PPL, a number of firms have released research notes about the stock. BMO Capital Markets stated their Outperform rating for the stock in a research note on December 11, 2024, with the firm’s price target at $36. JP Morgan coverage for the PPL Corp (PPL) stock in a research note released on October 25, 2024 offered a Overweight rating with a price target of $37. Jefferies was of a view on September 20, 2024 that the stock is Buy, while Argus gave the stock Buy rating on March 08, 2024, issuing a price target of $30. UBS on their part issued Neutral rating on October 04, 2023.
